Latest Publications

Share:

Weighing Benefits and Risks: New Draft Guidance Offers Insights on FDA Decision-Making

In late September, the Food and Drug Administration (FDA) released a draft guidance on benefit-risk assessments for drugs and biological products. The draft guidance includes considerations the agency uses when weighing the...more

FDA Advances Patient Engagement via PDUFA VII Performance Goals

On August 23, 2021, the Food and Drug Administration released the PDUFA VII commitment letter, which contains the agency’s performance goals for the five-year window (Fiscal Year 2023 to 2027) covered by the next iteration of...more

Senate Republicans Plan to Release ‘Skinny’ COVID-19 Plan

Background - Amid the stalemate surrounding a new COVID-19 response bill, Senate Republicans are circulating a new COVID-19 stimulus package that they intend to serve as their response to the House Democrats’ $25 billion...more

Patient Perspectives—There’s an App for That!

On November 7, the U.S. Food and Drug Administration (FDA) announced the launch of the MyStudies app, the latest in a series of concrete activities to drive the integration of the patient voice in clinical trials and the drug...more

4 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide